-
公开(公告)号:US20050227171A1
公开(公告)日:2005-10-13
申请号:US11091666
申请日:2005-03-28
申请人: Daisuke Kawana , Tomotaka Yamada , Hiroshi Shimbori , Koki Tamura , Tomoyuki Ando , Takayuki Hosono
发明人: Daisuke Kawana , Tomotaka Yamada , Hiroshi Shimbori , Koki Tamura , Tomoyuki Ando , Takayuki Hosono
CPC分类号: G03F7/0045 , G03F7/0757
摘要: A lift-off positive resist composition capable of forming a fine lift-off pattern is provided. This composition comprises a base resin component (A) and an acid generator component (B) generating an acid under exposure, wherein the base resin component (A) is a silicone resin.
摘要翻译: 提供能够形成微细剥离图案的剥离正型抗蚀剂组合物。 该组合物包含产生暴露酸的基础树脂成分(A)和产酸成分(B),其中,所述基础树脂成分(A)为有机硅树脂。
-
62.
公开(公告)号:US06638530B1
公开(公告)日:2003-10-28
申请号:US10069582
申请日:2002-02-27
IPC分类号: A61K966
CPC分类号: C07D213/30 , C07D213/65 , C07D213/75
摘要: There are provided pharmaceutical formulations with improved oral absorptivity and injections that contain, as active ingredients, high concentrations of benzamide derivatives and their pharmaceutically acceptable salts, which are useful as histone deacetylase inhibitors. A pharmaceutical solution is prepared by dissolving a benzamide derivative or a pharmaceutically acceptable salt thereof in an organic solvent and/or acidic liquid, and a pharmaceutical formulation is prepared by adding a surfactant, an acidic substance and/or a polyethylene glycol. The present invention has enabled dissolution of benzamide derivatives or their pharmaceutically acceptable salts at high concentrations, to prepare practical injections and oral liquid formulations and improve absorptivity with oral administration.
摘要翻译: 提供具有改进的口服吸收性和注射剂的药物制剂,其含有作为活性成分的高浓度苯甲酰胺衍生物及其药学上可接受的盐,其可用作组蛋白脱乙酰酶抑制剂。药物溶液通过将苯甲酰胺衍生物或药物 在有机溶剂和/或酸性液体中可接受的盐,并且通过加入表面活性剂,酸性物质和/或聚乙二醇制备药物制剂。本发明使苯甲酰胺衍生物或其药学上可接受的盐在高温下溶解 浓度,以制备实用的注射剂和口服液体制剂,并通过口服给药改善吸收性。
-
公开(公告)号:US06174905B1
公开(公告)日:2001-01-16
申请号:US08935087
申请日:1997-09-26
申请人: Tsuneji Suzuki , Tomoyuki Ando , Katsutoshi Tsuchiya , Osamu Nakanishi , Akiko Saito , Takashi Yamashita , Yoshinori Shiraishi , Eishi Tanaka
发明人: Tsuneji Suzuki , Tomoyuki Ando , Katsutoshi Tsuchiya , Osamu Nakanishi , Akiko Saito , Takashi Yamashita , Yoshinori Shiraishi , Eishi Tanaka
IPC分类号: A61K3144
CPC分类号: C07D213/30 , C07C233/80 , C07C237/42 , C07C255/57 , C07C271/20 , C07C275/24 , C07C275/40 , C07C335/16 , C07C335/20 , C07D207/34 , C07D211/22 , C07D213/38 , C07D213/40 , C07D213/50 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/65 , C07D213/74 , C07D213/75 , C07D213/81 , C07D213/82 , C07D215/48 , C07D215/54 , C07D231/12 , C07D233/56 , C07D233/64 , C07D233/90 , C07D241/12 , C07D241/24 , C07D249/08 , C07D261/08 , C07D261/18 , C07D263/24 , C07D275/03 , C07D277/24 , C07D277/40 , C07D295/088 , C07D307/12 , C07D307/68 , C07D333/16 , C07D333/70 , C07D401/06 , C07D405/12 , C07D413/12 , C07D453/02 , C07D491/04
摘要: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.
摘要翻译: 由式(1)表示的新型苯甲酰胺衍生物和本发明式(13)表示的新型酰苯胺衍生物具有诱导分化作用,因此可用于恶性肿瘤,自身免疫疾病,皮肤病的治疗或改善剂 和寄生。 特别是作为抗癌药物,特别是血液恶性肿瘤和实体癌是非常有效的。
-
-